Relationship between Gastric Inflammatory Response and Symptoms in Patients Infected with Helicobacter pylori

References

• Krienitz W. Ueber das auftreten von mageninhalt bie carcinoma ventriculi. Dtsch Med Wochenshr 1906; 22: 872
   Google Scholar
• Doenges J L. Spirochaetes in the gastric glands of Macacus rhesus and of man without related disease. Arch Pathol 1939; 31: 469–477
   Google Scholar
• Freedburg A S, Barron L E. The presence of spirochaetes in human gastric mucosa. Am J Dig Dis 1940; 7: 443–445
   Google Scholar
• Steer H W. Ultra structure of cell migration through the gastric epithelium and its relationship to bacteria. J Clin Pathol 1975; 28: 639–646
   PubMed Web of Science ®Google Scholar
• Palmer E D. Investigation of the gastric mucosa spirochetes of the human. Gastroenterology 1954; 27: 218–220
   PubMed Web of Science ®Google Scholar
• Warren J R. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273
   PubMed Web of Science ®Google Scholar
• Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273–1275
   PubMed Web of Science ®Google Scholar
• Marshall B J, Warren J R. Unidentified curved bacillin in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311–1314
   PubMed Web of Science ®Google Scholar
• Booth L, Holdstock G, MacBnde H, et al. Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endos-copy. J Clin Pathol 1986; 39: 215–219
   PubMed Web of Science ®Google Scholar
• Skoglund M L, Whalen J, Krajden K, Bohnen J, Matlow A. Detection of Campylobacter pyloridis infection in a Toronto population with a simple non-invasive assay of serum IgG antibodies [Abstract]. Am J Gastroenterol 1986; 81: 850
   Web of Science ®Google Scholar
• Czinn S J, Carr H, Sheffler L, Aronoff S. Serum IgG antibody to the outer membrane proteins of Campylobacter pylori in children with gastro-duodenal disease. J Infect Dis 1989; 159: 586–589
   PubMed Web of Science ®Google Scholar
• Czinn S J, Carr H S, Speck W T. The diagnosis of Helicobacter pylori gastritis using an enzyme linked immunoassay. Rev Infect Dis 1990, (in press)
   Google Scholar
• Rathbone B J, Wyatt J I, Worsley B W, et al. Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut 1986; 27: 642–647
   PubMed Web of Science ®Google Scholar
• Marshall B J, Armstrong J A, McGechie D B, Glancy R J. Attempt to fulfill Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436–439
   PubMed Web of Science ®Google Scholar
• Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192–199
   PubMed Web of Science ®Google Scholar
• Rauws E AJ, Langerberg W, Houthoff H J, Zanen H C, Tytgat G NJ. Campylobacter pyloridis-associ-ated chronic active antral gastritis. Gastroenterology 1988; 94: 33–40
   PubMedGoogle Scholar
• McNulty C AM, Dent J, Wise R. Susceptibility of clinical isolates of Campylobacter pylori to 11 antimicrobial agents. Antimicrob Agents Chemother 1985; 28: 837–838
   PubMed Web of Science ®Google Scholar
• Humphreys H, Bourke S, Dooley C, et al. Effect of treatment on Campylobacter pylori in peptic disease: a randomized prospective trial. Gut 1988; 29: 279–283
   PubMed Web of Science ®Google Scholar
• Humphreys H, Bourke S, Dooley C, McKenna D, et al. Effect of treatment on Campylobacter pylori in peptic disease: a randomized prospective trial. Gut 1988; 29: 279–283
   PubMed Web of Science ®Google Scholar
• Marshall B J, Goodwin C S, Warren J R, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–1442
   PubMed Web of Science ®Google Scholar
• Rauws E AJ. Therapeutic attempts at eradication of Campylobacter pylori. Eur J Gastroenterol Hepatol 1989; 1: 34–41
   Google Scholar
• Rauws E AJ, Langenberg W, Houthoff H J, et al. Antibacterial action of bismuth in relation to Campylobacter pyloridis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antinuclear treatment. Gastroenterology 1988; 94: 33–40
   PubMed Web of Science ®Google Scholar
• Dunnill M A, Whitehead R. A method for the quantitation of small intestinal biopsy specimens. J Clin Pathol 1972; 25: 243–246
   PubMed Web of Science ®Google Scholar
• Elias H, Hyde D. A guide to practical stereology. S. Karger, Basel 1983; Vol. 1, (Karger Continuing Education Series)
   Google Scholar
• Talley N J, Phillips S F. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med 1988; 108: 865–879
   PubMed Web of Science ®Google Scholar
• Caldwell S H, Valenzuela G, Marshall B J, et al. Campylobacter pylori (CP) gastritis does not slow solid-phase Tc99 gastric emptying. American College of Gastroenterology 54th Annual Scientific Meeting. Am J Gastroenterol 1989; 84: 1155
   Google Scholar
• Paull G, Yardley J H. Pathology of C. pylori-associated gastric and esophageal lesions. Campylobacter pylori in gastritis and peptic ulcer disease, M J Blaser. Igaku-Shoin Medical Publishers, Inc., New York, N.Y. 1989; 73–98
   Google Scholar
• Rokkas T C, Pursey C, Uzoechina E. Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol 1987; 82: 1149–1152
   PubMed Web of Science ®Google Scholar
• Marshall B J, Goodwin C S, Warren J R, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437
   PubMed Web of Science ®Google Scholar
• Rokkas T, Pursey C, Uzoechina E, et al. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori. Gut 1991; 29: 1306
   Google Scholar